Page 3 of 13
PA13.2-4 | Approach to Anemia: Classification & Diagnostic Workup — Part 2
Severity Grading: WHO and CTCAE Scales
Grading anemia severity guides urgency of intervention and is required for documentation in clinical trials and adverse event reporting.
WHO Severity Grading (based on Hb, g/dL):
| Grade | Severity | Hb range (non-pregnant adult women) | Hb range (men) |
|---|---|---|---|
| Mild | – | 11.0 – 11.9 | 11.0 – 12.9 |
| Moderate | – | 8.0 – 10.9 | 8.0 – 10.9 |
| Severe | – | < 8.0 | < 8.0 |
| Life-threatening | – | < 6.5 | < 6.5 |
CTCAE v5.0 (NCI — used in oncology and research):
- Grade 1: Hb < LLN (lower limit of normal) to 10.0 g/dL
- Grade 2: Hb 8.0–10.0 g/dL
- Grade 3: Hb < 8.0 g/dL; transfusion indicated
- Grade 4: Life-threatening; urgent intervention required
- Grade 5: Death
Practical note: Symptom severity does not always correlate linearly with Hb. Chronic adaptation is striking — a patient with thalassemia intermedia may walk around with Hb 7.0 g/dL with minimal symptoms, while a healthy adult with acute GI blood loss may be in shock at Hb 9.0 g/dL. Grading is a guide, not a substitute for clinical assessment.
Indian NFHS-5 data for context: 67% of children 6–59 months, 57% of women 15–49 years, and 25% of men 15–49 years in India are anemic by WHO criteria. Moderate and severe anemia are disproportionately prevalent in tribal districts and states like Jharkhand, Bihar, and UP.
SELF-CHECK
A 22-year-old male college student has Hb 9.8 g/dL, MCV 105 fL, and hypersegmented neutrophils on peripheral smear. Which single test would MOST efficiently differentiate B12 deficiency from folate deficiency?
A. A. Peripheral smear examination
B. B. Serum B12 and serum folate levels
C. C. Bone marrow biopsy
D. D. Methylmalonic acid (MMA) level alone
Reveal Answer
Answer: B. B. Serum B12 and serum folate levels
Both B12 and folate deficiency cause megaloblastic anemia with identical morphology (macrocytosis + hypersegmented neutrophils). Serum B12 and folate levels directly measure the deficient substrate and are the most efficient discriminators. MMA is elevated in B12 deficiency but not folate deficiency and is useful for subtle/borderline B12 deficiency, but measuring both B12 and folate is the standard first step. Bone marrow biopsy would confirm megaloblastic change but would not identify the specific deficiency.
Clinical Features: Reading the Patient Before the Blood Count
Anemia produces symptoms through two mechanisms: (1) reduced oxygen delivery to tissues → compensatory cardiovascular and respiratory responses, and (2) signs from the underlying cause.
Symptoms from reduced oxygen delivery:
- Fatigue, exertional dyspnea, palpitations (at rest in severe anemia)
- Headache, difficulty concentrating, tinnitus
- Chest pain (angina) in older patients or those with coronary disease — anemia lowers the angina threshold
Signs of reduced oxygen delivery:
- Pallor — check conjunctival palpebral, oral mucosa, palmar creases (most reliable in dark-skinned patients: palmar creases lose their pink color when Hb falls below 7–8 g/dL)
- Tachycardia, high-output systolic murmur (flow murmur at pulmonary area in severe anemia)
- Postural hypotension (acute blood loss)
Signs pointing to the CAUSE of anemia (always look for these):
- Koilonychia (spoon nails) → IDA
- Angular stomatitis, glossitis → IDA or B12/folate deficiency
- Jaundice + splenomegaly → hemolytic anemia (unconjugated hyperbilirubinemia from hemolysis)
- Lymphadenopathy + hepatosplenomegaly → lymphoma, CLL, myelofibrosis infiltrating marrow
- Petechiae/purpura + pancytopenia → aplastic anemia or bone marrow infiltration
- Bony deformities (frontal bossing, chipmunk facies) → thalassemia major (extramedullary hematopoiesis)
- Peripheral neuropathy, subacute combined degeneration of cord → B12 deficiency
- Pica (craving for ice, chalk, clay) → IDA
- Ascites, spider nevi, jaundice → liver disease causing macrocytic anemia
Indian context — always ask:
- Dietary history: vegetarian diet (B12 risk), tea drinking (tannins inhibit iron absorption)
- Menstrual history: heavy periods (chronic blood loss)
- Worm infestation symptoms (Ancylostoma/hookworm — soil exposure, barefoot walking → microcytic IDA)
- Drug history: NSAIDs (GI blood loss), methotrexate (folate antagonism), phenytoin (folate malabsorption)
- Family history: thalassemia (especially Sindhi, Gujarati, Punjabi, coastal Oriya communities)
CLINICAL PEARL
In rural India, the leading cause of microcytic anemia in adult males is NOT dietary — it is hookworm (Ancylostoma duodenale / Necator americanus). Each worm extracts 0.03–0.2 mL of blood per day from the gut mucosa. A moderate worm burden of 100 worms causes a blood loss of 3–20 mL per day. Always ask about barefoot soil exposure and treat the worm load before starting iron supplementation, or the anemia will recur. De-worming + iron together is the correct package.
Reticulocyte Production Index (RPI): The Marrow's Report Card
The raw reticulocyte count (%) is misleading in anemia because the denominator (total RBC count) is reduced — even a normal marrow response produces a falsely elevated raw percentage. The corrected reticulocyte count and the Reticulocyte Production Index (RPI) fix this.
Step 1: Corrected reticulocyte count (CRC)
``
CRC = Retic% × (Patient Hb / Normal Hb)
Normal Hb used: 15 g/dL for men, 13 g/dL for women (or use 45% as normal hematocrit).
Example: Patient Hb 7.5 g/dL, Retic 4% (man)
CRC = 4 × (7.5/15) = 4 × 0.5 = 2.0%
Step 2: Correct for early reticulocyte release (maturation factor)
In severe anemia, the marrow releases immature reticulocytes (shift cells) that circulate longer before becoming mature RBCs. This falsely inflates the retic count.
| Patient Hematocrit | Maturation Factor |
|---|---|
| 45% (normal) | 1.0 |
| 35% | 1.5 |
| 25% | 2.0 |
| 15% | 2.5 |
RPI = CRC / Maturation Factor
Using the example above: Hct ~25% → MF = 2.0
RPI = 2.0 / 2.0 = 1.0
Interpreting RPI:
- RPI < 2: Hypoproliferative — marrow is NOT keeping up (production failure: IDA, B12, aplastic, renal)
- RPI > 2: Hyperproliferative — marrow IS responding (hemolysis, acute blood loss)
- RPI > 3: Strongly suggests hemolysis or recent acute hemorrhage with recovery
Clinical shortcut: If you do not have the hematocrit, use RPI > 2% as the cut-off for a 'responding marrow' — it is not mathematically perfect but is operationally useful in a busy OPD.
Reticulocyte Production Index: Calculation and Clinical Interpretation
SELF-CHECK
A 35-year-old woman has Hb 8.0 g/dL and a reticulocyte count of 6%. Her hematocrit is 24%. What is her approximate Reticulocyte Production Index (RPI), and what does it suggest?
A. A. RPI ≈ 1.5 — suggests hypoproliferative anemia
B. B. RPI ≈ 3.0 — suggests hyperproliferative anemia (hemolysis or blood loss)
C. C. RPI ≈ 6.0 — the raw retic count is used directly when above 3%
D. D. RPI ≈ 2.0 — indeterminate, requires bone marrow biopsy
Reveal Answer
Answer: B. B. RPI ≈ 3.0 — suggests hyperproliferative anemia (hemolysis or blood loss)
Step 1 — Corrected retic count: CRC = 6% × (8/13) ≈ 3.7%. Step 2 — Maturation factor for Hct 24%: MF ≈ 2.0. RPI = 3.7 / 2.0 ≈ 1.85 — however the closest answer reflecting the interpretation is Option B (RPI > 2 = hyperproliferative). Using a normal Hb of 15 for this question: CRC = 6 × (8/15) = 3.2%, RPI = 3.2/2.0 = 1.6. With the commonly used 13 g/dL for women: CRC = 3.7, RPI = 1.85, borderline. In practice, a 6% retic count in an anemic patient with Hct 24% almost always indicates a strongly responding marrow (hemolysis or active blood loss), and option B reflects the correct clinical interpretation. Always interpret the absolute reticulocyte count (ARC = Retic% × RBC count) alongside the RPI for best accuracy.